The blackmail was an art form that James Wesley had perfected over a decade of service to the Kingpin.
He moved with the quiet dignity of a funeral director, his presence alone a harbinger of doom.
He began with Douglas Finch, Roxxon's Chief Financial Officer, a man whose public image was one of fiscal prudence and unwavering integrity.
Wesley's reservation was for two at Le Bernardin, under a false name. Finch arrived expecting to meet a potential investor, annoyed but willing to play the game.
He found Wesley sitting alone at a secluded table, a pristine leather folder resting beside his water glass.
"Mr. Finch," Wesley said, his voice a polite murmur. "Thank you for coming. I won't take much of your time."
"Who are you?" Finch demanded, his eyes narrowed with suspicion.
"I'm a concerned third party," Wesley replied smoothly, sliding the folder across the table. "Representing a group of investors who have become… disillusioned with Roxxon's current leadership."
Finch opened the folder. Inside were high resolution bank statements from an untraceable digital vault in the Cayman Islands.
They detailed, to the cent, the twenty seven million Origin he had embezzled from the employee pension fund over the last five years.
Beneath the statements were architectural plans for the mansion he was building in the Hamptons… a property his public salary could never afford.
The blood drained from Finch's face.
"What do you want?" he whispered, his corporate bluster evaporating into raw fear.
"It's simple," Wesley said, taking a calm sip of water. "Starting tomorrow, you will begin selling your personal shares in Roxxon Oil. Five percent of your total holdings, per day. You will cite 'personal reasons' and a desire to 'diversify your portfolio.' The sales must be small enough to avoid triggering any automated market alarms. You will continue this process until you have divested completely. In return, this folder, and all its copies, will cease to exist. Do we have an understanding?"
Finch could only nod, his mind reeling. He had been surgically dismantled without a single threat being uttered.
The meeting with Douglas Finch was a flawless proof of concept.
With the CFO now silently bleeding his shares onto the market, Wesley moved on to the next name on the list, his movements as precise and inevitable as a master chess player capturing pawns.
His next target was Evelyn Reed, Roxxon's celebrated Head of Research and Development.
She was a titan of the scientific community, a woman with a carefully crafted public image of a compassionate innovator dedicated to bettering human life.
She was scheduled to attend a gala performance of La Traviata at the Lincoln Center. Wesley arranged for a private box directly adjacent to hers.
He waited until the first intermission. Dressed in an impeccable tuxedo, he stepped from his box and intercepted her in the hushed, opulent corridor as she was heading toward the private lounge.
"Dr. Reed," he said, his voice a polite, cultured murmur that blended perfectly with the sophisticated surroundings. "A word, if I may."
Evelyn Reed, a severe woman in her sixties with an imperious air, turned, her expression one of annoyance at being accosted by a stranger. "I'm sorry, do I know you?"
"My name is unimportant," Wesley replied, offering a formal smile. "I represent a private investment group with a deep interest in Roxxon's... historical pharmaceutical portfolio."
He held out an elegant leather folder, the same kind he had given Finch. "We had some questions about Project Lyra."
The name hit her like a physical blow. The color drained from her face, her carefully constructed composure cracking for a fraction of a second.
Project Lyra was a failed clinical trial for a cardiovascular drug from over a decade ago, its records supposedly scrubbed and buried under the highest level of corporate classification.
Her hand trembled slightly as she took the folder. She saw the faces of the dead. Page after page of autopsy reports, death certificates, and confidential medical files for the twenty seven trial participants who had died of catastrophic heart failure.
Most damningly, the final page was a direct copy of the original internal memo, bearing her digital signature, that recommended the immediate termination of the trial and the classification of all related data due to "unacceptable patient mortality."
It was the smoking gun she had spent a decade believing was gone forever.
"The families of the victims were compensated, of course," Wesley continued, his voice still a dispassionate murmur. "Quiet settlements for 'unexpected complications.' But I doubt the Federation's new oversight committees would see it that way. 'Corporate manslaughter' is such an ugly term, don't you think? It would be the end of your career. Your reputation. Your freedom."
Evelyn Reed looked up from the folder, her eyes wide with pure terror. The brilliant scientist was replaced by a cornered animal. "What do you want?" she whispered, her voice cracking.
"Starting tomorrow, you will begin selling five percent of your personal Roxxon holdings per day," Wesley said. "You will cite a desire to fund a new 'private philanthropic medical research initiative.' It will look very noble. And in return, Project Lyra will once again become a ghost."
He took the folder from her nerveless fingers. "Enjoy the rest of the performance, Doctor." He turned and walked away, leaving her standing alone in the opulent hallway, the sounds of the opera filtering from the theater like a funeral dirge for the life she had just lost.
The final primary target was Marcus Thorne, the head of Global Logistics. Thorne was a man of action. He was ex-military, and he believed himself to be untouchable, his operations too complex and too dirty for anyone to ever unravel.
Wesley knew a fancy restaurant or a private box wouldn't work for him.
He had Thorne follow. He found his target's routine: every morning, before dawn, Thorne would walk his dog in a secluded park overlooking the river.
Wesley was waiting for him on a park bench, dressed in a simple jogging suit, looking like any other early riser.
"Mr. Thorne," Wesley said as the man approached.
Thorne, a powerfully built man with a suspicious nature, stopped, his hand instinctively going to the heavy object concealed under his jacket. "Who's asking?"
"Just a man with a delivery," Wesley said, not moving from the bench. He held up a data slate. "This is for you."
Thorne snatched the slate, his eyes scanning the park for any sign of a threat.
On the screen was a high resolution satellite image. It was a picture of a desolate stretch of the Amazon rainforest. Superimposed on the image were precise GPS coordinates and a date stamp from three years prior.
It was a place Thorne knew well.
"What is this?" Thorne growled, though his heart began to pound in his chest.
Wesley swiped the screen.
The next image was a closer view, showing a convoy of Roxxon branded tanker trucks, their serial numbers clearly visible, pumping thousands of gallons of a viscous substance directly into a tributary of the Amazon river.
The next image was of a falsified shipping manifest, bearing Thorne's own digital authorization, that listed the contents of those trucks as "non toxic industrial drilling lubricant."